- Home
- CPHI vs NLSP Comparison
CPHI vs NLSP Comparison
Compare CPHI & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- NLSP
- Stock Information
- Founded
- CPHI N/A
- NLSP 2015
- Country
- CPHI China
- NLSP Switzerland
- Employees
- CPHI N/A
- NLSP N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- CPHI Health Care
- NLSP Health Care
- Exchange
- CPHI Nasdaq
- NLSP Nasdaq
- Market Cap
- CPHI 5.4M
- NLSP 5.8M
- IPO Year
- CPHI N/A
- NLSP 2021
- Fundamental
- Price
- CPHI $2.22
- NLSP $1.62
- Analyst Decision
- CPHI
- NLSP
- Analyst Count
- CPHI 0
- NLSP 0
- Target Price
- CPHI N/A
- NLSP N/A
- AVG Volume (30 Days)
- CPHI 85.3K
- NLSP 26.4K
- Earning Date
- CPHI 05-23-2025
- NLSP 05-27-2025
- Dividend Yield
- CPHI N/A
- NLSP N/A
- EPS Growth
- CPHI N/A
- NLSP N/A
- EPS
- CPHI N/A
- NLSP N/A
- Revenue
- CPHI $4,295,377.00
- NLSP N/A
- Revenue This Year
- CPHI N/A
- NLSP N/A
- Revenue Next Year
- CPHI N/A
- NLSP N/A
- P/E Ratio
- CPHI N/A
- NLSP N/A
- Revenue Growth
- CPHI N/A
- NLSP N/A
- 52 Week Low
- CPHI $1.20
- NLSP $1.30
- 52 Week High
- CPHI $4.10
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- CPHI 56.97
- NLSP 53.77
- Support Level
- CPHI $2.08
- NLSP $1.58
- Resistance Level
- CPHI $2.50
- NLSP $1.75
- Average True Range (ATR)
- CPHI 0.23
- NLSP 0.10
- MACD
- CPHI 0.06
- NLSP 0.01
- Stochastic Oscillator
- CPHI 63.64
- NLSP 55.73
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.